{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:17Z","timestamp":1793226797875,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007760","name":"The Ohio State University College of Medicine Office of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.surg.2026.110492","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:46:47Z","timestamp":1785426407000},"page":"110492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Drugs are not cutting it: Patient motivations for metabolic and bariatric surgery despite glucagon-like peptide-1 use"],"prefix":"10.1016","volume":"199","author":[{"given":"Aryaman","family":"Dass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie C.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa N.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace F.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-6482","authenticated-orcid":false,"given":"Patrick J.","family":"Sweigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.surg.2026.110492_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"25 Suppl 2","key":"10.1016\/j.surg.2026.110492_bib2","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS Guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.surg.2026.110492_bib3","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.surg.2026.110492_bib4","series-title":"NCHS Data Briefs [Internet]","article-title":"Obesity and Severe Obesity Prevalence in Adults: United States, August 2021\u2013August 2023. 2024 Sep","volume":"No. 508","author":"Emmerich","year":"2024"},{"key":"10.1016\/j.surg.2026.110492_bib5","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2026.110492_bib6","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","article-title":"A cost comparison of GLP-1 receptor agonists and bariatric surgery; what is the break even point?","volume":"38","author":"Docimo","year":"2024","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2026.110492_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2014.16968","article-title":"Association between bariatric surgery and long-term survival","volume":"313","author":"Arterburn","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2026.110492_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/SLA.0000000000005003","article-title":"Patient-reported outcomes after metabolic surgery versus medical therapy for diabetes: insights from the STAMPEDE randomized trial","volume":"274","author":"Aminian","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110492_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","article-title":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial","volume":"386","author":"Mingrone","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2026.110492_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2026.110492_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2026.110492_bib12","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1007\/s11695-021-05455-1","article-title":"Long-term results of one anastomosis gastric bypass: a single center experience with a minimum follow-up of 10 years","volume":"31","author":"Carandina","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2026.110492_bib13","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s11695-021-05394-x","article-title":"What is weight loss after bariatric surgery expressed in percentage total weight loss (%TWL)? A systematic review","volume":"31","author":"van Rijswijk","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2026.110492_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.soard.2022.03.020","article-title":"Five-year weight loss, physical activity, and eating style trajectories after bariatric surgery","volume":"18","author":"Voorwinde","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2026.110492_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2026.110492_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2026.110492_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajhp\/zxad086","article-title":"National trends in prescription drug expenditures and projections for 2023","volume":"80","author":"Tichy","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.surg.2026.110492_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014-2022","volume":"64","author":"Watanabe","year":"2024","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.surg.2026.110492_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamasurg.2026.0049","article-title":"Trends in metabolic and bariatric surgery use during the GLP-1 receptor agonist era","volume":"161","author":"Rohde","year":"2026","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2026.110492_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.soard.2023.01.021","article-title":"Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery","volume":"19","author":"Cunningham","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2026.110492_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity treatment with bariatric surgery vs GLP-1 receptor agonists","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2026.110492_bib22","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","article-title":"Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study","volume":"37","author":"Ilanga","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2026.110492_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jss.2022.10.061","article-title":"Patient and the public\u2019s perceptions of bariatric surgery: a systematic review","volume":"283","author":"Rajeev","year":"2023","journal-title":"J Surg Res"},{"key":"10.1016\/j.surg.2026.110492_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/cob.12131","article-title":"Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity","volume":"6","author":"Wharton","year":"2016","journal-title":"Clin Obes"},{"key":"10.1016\/j.surg.2026.110492_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s11695-022-05928-x","article-title":"Understanding racially diverse community member views of obesity stigma and bariatric surgery","volume":"32","author":"Chao","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2026.110492_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12325-019-00900-1","article-title":"Patient needs, perceptions, and attitudinal drivers associated with obesity: a qualitative online bulletin board Study","volume":"36","author":"Cook","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.surg.2026.110492_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/cts.2026.10473","article-title":"275 Patient perspectives on GLP-1 receptor agonists for weight loss: a mixed-methods study to inform translational obesity care","volume":"10","author":"McElroy","year":"2026","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.surg.2026.110492_bib29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"10.1016\/j.surg.2026.110492_bib30","series-title":"Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis","author":"Charmaz","year":"2006"},{"key":"10.1016\/j.surg.2026.110492_bib31","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1177\/10497323211024951","article-title":"Conceptualizing qualitative data","volume":"31","author":"Broom","year":"2021","journal-title":"Qual Health Res"},{"key":"10.1016\/j.surg.2026.110492_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40608-016-0123-3","article-title":"Barriers to weight loss among community health center patients: qualitative insights from primary care providers","volume":"3","author":"Woodruff","year":"2016","journal-title":"BMC Obes"},{"key":"10.1016\/j.surg.2026.110492_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2025.20301","article-title":"Combining medications with bariatric surgery to treat obesity","volume":"335","author":"Morton","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2026.110492_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae284","article-title":"Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review","volume":"111","author":"Cohen","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2026.110492_bib35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cgh.2016.10.023","article-title":"White paper AGA: POWER \u2013 practice guide on obesity and weight management, education, and resources","volume":"15","author":"Acosta","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2026.110492_bib36","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.surg.2026.110492_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026004174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026004174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:09:56Z","timestamp":1793225396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026004174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0039606026004174"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110492","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs are not cutting it: Patient motivations for metabolic and bariatric surgery despite glucagon-like peptide-1 use","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110492"}}